December 2021 FDA Recall Drug by Remedyrepack Inc.
D-0366-2022 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on December 30, 2021 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Product was distributed to one direct account in PA. and the recall is currently terminated.

Recall Number: D-0366-2022

Reason for Recall
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Initiated
12-30-2021
Reported
01-19-2022
Quantity
56 Blister Cards

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed to one direct account in PA.
Metformin 750 mg Extended Release NDC # 70518-2920-00

Batch or Lot Expiration Information

Lot# J0511265-021121, exp. date 02/28/2022 J0499451-122220, exp. date 01/31/2022 J0496563-120820, exp. date 12/31/2021 J0495111-120120, exp. date 12/31/2021